Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Delta-like 4 is required for pulmonary vascular arborization and alveolarization in the developing lung
Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath
Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath
View: Text | PDF
Research Article Pulmonology Vascular biology

Delta-like 4 is required for pulmonary vascular arborization and alveolarization in the developing lung

  • Text
  • PDF
Abstract

The molecular mechanisms by which endothelial cells (ECs) regulate pulmonary vascularization and contribute to alveolar epithelial cell development during lung morphogenesis remain unknown. We tested the hypothesis that delta-like 4 (DLL4), an EC Notch ligand, is critical for alveolarization by combining lung mapping and functional studies in human tissue and DLL4-haploinsufficient mice (Dll4+/lacz). DLL4 expressed in a PECAM-restricted manner in capillaries, arteries, and the alveolar septum from the canalicular to alveolar stage in mice and humans. Dll4 haploinsufficiency resulted in exuberant, nondirectional vascular patterning at E17.5 and P6, followed by smaller capillaries and fewer intermediate blood vessels at P14. Vascular defects coincided with polarization of lung EC expression toward JAG1-NICD-HES1 signature and decreased tip cell-like (Car4) markers. Dll4+/lacZ mice had impaired terminal bronchiole development at the canalicular stage and impaired alveolarization upon lung maturity. We discovered that alveolar type I cell (Aqp5) markers progressively decreased in Dll4+/lacZ mice after birth. Moreover, in human lung EC, DLL4 deficiency programmed a hypersprouting angiogenic phenotype cell autonomously. In conclusion, DLL4 is expressed from the canalicular to alveolar stage in mice and humans, and Dll4 haploinsufficiency programs dysmorphic microvascularization, impairing alveolarization. Our study reveals an obligate role for DLL4-regulated angiogenesis in distal lung morphogenesis.

Authors

Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath

×

Figure 5

Dysmorphic vascular development in Dll4 mutant mice.

Options: View larger image (or click on image) Download as PowerPoint
Dysmorphic vascular development in Dll4 mutant mice.
(A) PECAM (green) w...
(A) PECAM (green) whole-mount staining on E14.5 Dll4+/+ and Dll4+/lacZ mouse lungs, n = 4 per group. (B) PECAM (brown) and Harris Hematoxylin (H) (blue) staining on E17.5 Dll4+/+ and Dll4+/lacZ mouse lungs. PECAM staining indicates much denser vascular structure in Dll4+/lacZ mouse lung at canalicular stage. Note: Lack of bronchioles in Dll4+/lacZ lung, n = 5 per group. (C) PECAM (brown) and fast red (red) staining on P6 Dll4+/+ and Dll4+/lacZ mouse lungs. A double capillary network was visualized in Dll4+/+ mice, but “whorls” of misaligned network were found in Dll4+/lacZ mouse lung at early alveolar stage, n = 4 per group. The arrow points to the double capillary in the left panel, and the arrow points to the misaligned network in the right panel. (D and F) PECAM (brown) and H staining on P14 Dll4+/+ and Dll4+/lacZ mouse lungs. The arrows in (D) point to intermediate blood vessels, and the arrows in (F) point to the capillaries, with quantifications shown for intermediate blood vessel number (E) and capillary thickness (G), which were less at P14 in Dll4+/lacZ mouse lung. n = 5 mice per group, **P < 0.01, ***P < 0.001. (H) Ki67 (green), ERG (red), and DAPI (blue) staining on P14 mouse lung slides, with quantifications shown for Ki67+ cells percentage in total ERG+ cells (I). n = 6 mice per group, P < 0.05. The arrows in (H) point to Ki67+ERG+ cells. Scale bars: 100 μm (A); 200 μm (B); 100 μm (C); 25 μm (D and F); 10 μm (H). Data are shown as mean ± SD. (D, G, and F) One-way ANOVA with Tukey’s test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts